Funding for Global Research and Training
The Center for Global Health helps reduce the global burden of cancer by strengthening research capacity through funding and training. Below you will find the most recent funding opportunities that are relevant to our work.
Current Funding Opportunities
Learn more about current international cancer research and cancer control funding opportunities developed by CGH, or supported by NCI in collaboration with other NIH Institutes and Centers or research organizations.
Research Administrative Supplement for Research on Bioethical Issues (Clinical Trial Optional)
The NIH Office of Science Policy, within the Office of the Director, announces the availability of administrative supplements to support research on bioethical issues to develop an evidence base that may inform future policy directions. The National Cancer Institute (NCI) is interested in bioethics issues relevant to cancer research and care, such as issues raised in cancer clinical trials, cancer cohorts, cancer prevention studies, cancer centers, prospective biobanking, or projects using existing samples/tissues. PA-19-217 Additional information may be found here: https://epi.grants.cancer.gov/bioethics-cancer-research.html.
U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (HIV/AIDS)
The purpose of these funding opportunities is to establish Phase 2 of the U.S.-South Africa Program for Collaborative Biomedical Research. The National Cancer Institute seeks to support HIV/AIDS-associated malignancies research under this program to foster, stimulate, and/or expand basic, translational, behavioral and applied research that will advance scientific discovery and engage U.S. and South African researchers working collaboratively in these areas. RFA-AI-19-022 (R01- clinical trial optional); RFA-AI-19-023 (U01- clinical trial optional).
The purpose of this funding opportunity announcement is to stimulate the development of novel microbial-based cancer therapies, especially for conditions where conventional cancer therapies are inadequate, such as poorly vascularized, hypoxic, solid tumors, dormant or slowly dividing cells resistant to current interventions, and brain tumors. PAR-19-194 (R21 for early stage research); PAR-19-193 (R01 for mature projects). Examples of Applications: (RO1, R21s).
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (Clinical Trial Optional)
These funding opportunities encourage Small Business Innovation Research (SBIR and STTR) grant applications from small business concerns (SBCs) proposing commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries (LMICs), and low-resource settings in the U.S. PAR-18-801 (R43/R44); PAR-18-802 (R41/42). For more information about these funding opportunities, download presentations from the NCI SBIR-CGH Joint Informational Webinar: SBIR-CGH Webinar1; SBIR-CGH Webinar2.
Note: Direct-to-Phase II is allowed for PAR-18-801 https://grants.nih.gov/grants/guide/notice-files/NOT-CA-19-003.html.
Dissemination and Implementation Research in Health (Clinical Trial Optional)
This funding opportunity encourages research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices into public health, clinical practice, and community settings. PAR-18-007 (R01); PAR-18-017 (R21).
This funding opportunity encourages research grant applications that will identify, develop, evaluate and refine effective and efficient methods, systems, infrastructures, and strategies to disseminate and implement evidence-based health practices for public health, clinical practice, and community settings.
International Research Scientist Development Award (K01)
This funding opportunity supports intensive, mentored research career development for early stage investigators committed to a cancer research career. PAR-18-539 (Independent clinical trial not allowed). PAR-18-540 (Independent clinical trial required). For additional information, please visit Frequently Asked Questions for the International Research Scientist Development Award.
This funding opportunity supports U.S.- Caribbean collaborative research to develop or extend cohort or surveillance studies on chronic disease in the Caribbean region, aligned with existing, publicly available U.S. datasets.
These funding opportunities highlight research initiatives that align with the efforts of the Cancer Moonshot. Supported with existing or 21st Century Cures Act funds, featured announcements include open funding opportunities.
This funding opportunity supports high quality scientific conferences that are relevant to the NIH's mission and to the public health.
Previously Funded Initiatives
Learn more about CGH’s previously funded research grants and initiatives. Download list of CGH previously funded initiatives.
Learn more about training opportunities available to U.S. and international students, scientists, and health care professionals.
The Short-Term Scientist Exchange Program at the Center for Global Health, National Cancer Institute, promotes collaborative research between researchers at the NCI and foreign cancer researchers.
The U.S. National Cancer Institute (NCI) Center for Global Health post-baccalaureate fellowship provides recent college graduates who are planning to apply to graduate or professional (public health/research/medical/dental/nursing/pharmacy, etc.) school an opportunity to learn about supporting the cancer research enterprise at NCI. Fellows work with NCI staff to develop and implement projects that aim to strengthen cancer research globally. The fellowship includes a capstone project. The NCI Center for Global Health is particularly interested in applicants who have either volunteered or worked in a low- or middle-income country or with disadvantaged populations in high-income countries.
This program offers two short-term cancer prevention training courses in Rockville, MD to international scientists and healthcare professionals from LMICs and the All-Ireland Cancer Consortium (AICC).